| Antibiotic resistance markers in Burkholderia pseudomallei strain Bp1651 identified by genome sequence analysis JV Bugrysheva, D Sue, JE Gee, MG Elrod, AR Hoffmaster, LB Randall, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00010-17, 2017 | 61 | 2017 |
| Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm NL Podnecky, KA Rhodes, T Mima, HR Drew, S Chirakul, V Wuthiekanun, ... MBio 8 (5), 10.1128/mbio. 01357-17, 2017 | 47 | 2017 |
| Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance S Chirakul, MH Norris, S Pagdepanichkit, N Somprasong, LB Randall, ... Scientific Reports 8 (1), 10652, 2018 | 18 | 2018 |
| Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression KA Rhodes, N Somprasong, NL Podnecky, T Mima, S Chirakul, ... Microbiology 164 (9), 1156-1167, 2018 | 16 | 2018 |
| Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification S Chirakul, N Somprasong, MH Norris, V Wuthiekanun, N Chantratita, ... International journal of antimicrobial agents 53 (5), 582-588, 2019 | 15 | 2019 |
| Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model S Chirakul, T Bartpho, T Wongsurawat, S Taweechaisupapong, ... PLoS One 9 (8), e104313, 2014 | 13 | 2014 |
| Outer membrane vesicle vaccines from biosafe surrogates prevent acute lethal glanders in mice MH Norris, MSR Khan, S Chirakul, HP Schweizer, A Tuanyok Vaccines 6 (1), 5, 2018 | 12 | 2018 |
| Effective screening for double heterozygosity of Hb E/α0-thalassemia K Sanchaisuriya, S Chirakul, H Srivorakun, G Fucharoen, S Fucharoen, ... Annals of hematology 87, 911-914, 2008 | 12 | 2008 |
| GC-072, a novel therapeutic candidate for oral treatment of melioidosis and infections caused by select biothreat pathogens JD Shearer, ML Saylor, CM Butler, AM Treston, HS Heine, S Chirakul, ... Antimicrobial agents and chemotherapy 63 (12), 10.1128/aac. 00834-19, 2019 | 3 | 2019 |
| 2016 Postdoc Research Symposium EA Hall | | 2016 |
| Characterization of BPSS1521 (bprD), a Regulator of S Chirakul, T Bartpho, T Wongsurawat, S Taweechaisupapong, ... | | 2014 |
| Cutoff values of Hb E and MCV for screening of double heterozygosity for Hb E/alpha (0)-thalassemia K Sanchaisuriya, S Chirakul, H Srivorakun, G Fucharoen, Y Changtrakun, ... INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 29, 109-110, 2007 | | 2007 |
